Skip to main content

Shareholder Report

Shareholder Report
📁 Objectives
📁 Team
📁 Sales
📁 Financials
Board Meetings
Trajectory & Recognition
Cap Table
📝 Shareholder agreement

📁 Objectives
📁 2024
2024 Goals

2024 Goals

Following the seed funding round, 2024 was set to be a year of accelerated growth. The focus was on scaling revenue, expanding into new markets, and improving customer satisfaction metrics.

Revenue

Metric	Target	Baseline (2023)
Revenue	€870,369	€348,298
Growth	2.5x (150%)	—

Market Expansion

Target: 2 new markets

Strategy: Leverage existing European presence to expand into high-potential regions with strong healthcare infrastructure and regulatory alignment.

Customer Satisfaction

Metric	Target	Baseline
NPS	70%	60%

Focus: Improve Net Promoter Score through enhanced customer success processes and product improvements.

Revenue
Market Expansion
Customer Satisfaction

All the information contained in this data room is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)